The Overall and Gendered Effects of Postrelease Supervision on Recidivism: A Propensity Score Analysis

2019 ◽  
Vol 46 (7) ◽  
pp. 1020-1043 ◽  
Author(s):  
Amy D. Miller ◽  
Melissa S. Jones ◽  
Cyrus Schleifer
Keyword(s):  
Propensity Score ◽  
Justice System ◽  
Propensity Score Analysis ◽  
Effect Sizes ◽  
Criminological Research ◽  
Score Analysis ◽  
Reducing Recidivism ◽  
Matching Techniques ◽  
The Relationship

Although research recognizes gender differences in offending and interactions with the criminal justice system, few studies have explored the role of gender in the relationship between postrelease supervision and recidivism. Building on feminist criminological research, this study uses a feminist pathways theoretical framework to investigate the overall and gendered effects of postrelease supervision on multiple measures of recidivism. Using a large sample of offenders released from prisons in Florida ( N = 141,338) and propensity score matching techniques, this study uncovers that postrelease supervision is associated with a very small (4% to 4.5%) reduction in recidivism. Moreover, the effect sizes from the analyses also indicate that postrelease supervision plays a greater role in reducing recidivism among men, but the effects for women are much smaller. Based on this study’s findings, policymakers should consider the importance of gender in designing appropriate programming in prison and developing postrelease techniques in reducing recidivism.

Pattern of hepatocarcinoma recurrence in cirrhosis: The role of anatomic and parenchyma-sparing resection. A propensity score analysis

2018 ◽  
Vol 50 (1) ◽  
pp. 39
Author(s):  
S. Famularo ◽  
S. Di Sandro ◽  
A. Giani ◽  
A. Lauterio ◽  
F. Romano ◽  
...  
Keyword(s):  
Propensity Score ◽  
Propensity Score Analysis ◽  
Score Analysis ◽  
Parenchyma Sparing

scholarly journals Risk of severe maternal morbidity associated with cesarean delivery and the role of maternal age: a population-based propensity score analysis

2019 ◽  
Vol 191 (13) ◽  
pp. E352-E360 ◽  
Author(s):  
Diane Korb ◽  
François Goffinet ◽  
Aurélien Seco ◽  
Sylvie Chevret ◽  
Catherine Deneux-Tharaux ◽  
...  
Keyword(s):  
Propensity Score ◽  
Cesarean Delivery ◽  
Maternal Age ◽  
Maternal Morbidity ◽  
Propensity Score Analysis ◽  
Population Based ◽  
Severe Maternal Morbidity ◽  
Score Analysis

The role of valve surgery in infective endocarditis management: A systematic review of observational studies that included propensity score analysis

2008 ◽  
Vol 156 (5) ◽  
pp. 901-909 ◽  
Author(s):  
Imad M. Tleyjeh ◽  
Tarek Kashour ◽  
Valerie Zimmerman ◽  
James M. Steckelberg ◽  
Walter R. Wilson ◽  
...  
Keyword(s):  
Systematic Review ◽  
Infective Endocarditis ◽  
Propensity Score ◽  
Observational Studies ◽  
Propensity Score Analysis ◽  
Valve Surgery ◽  
Score Analysis

scholarly journals Role of routine drainage after hepatectomy in non-cirrhotic patients: A Multi-institutional French Propensity Score Analysis

HPB ◽  
2016 ◽  
Vol 18 ◽  
pp. e29
Author(s):  
M. Gelli ◽  
M.A. Allard ◽  
O. Farges ◽  
E. Vibert ◽  
F.-R. Pruvot ◽  
...  
Keyword(s):  
Propensity Score ◽  
Propensity Score Analysis ◽  
Score Analysis ◽  
Cirrhotic Patients

scholarly journals The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: A propensity score analysis

2008 ◽  
Vol 59 (7) ◽  
pp. 989-995 ◽  
Author(s):  
Roopa Seshadri ◽  
Brian M. Feldman ◽  
Norman Ilowite ◽  
Gail Cawkwell ◽  
Lauren M. Pachman
Keyword(s):  
Propensity Score ◽  
Corticosteroid Therapy ◽  
Juvenile Dermatomyositis ◽  
Propensity Score Analysis ◽  
Score Analysis

Chemotherapy rechallenge or reintroduction (CTr/r), regofenib (REG) and TAS-102 for metastatic pretreated colorectal cancer (mCRC) patients (pts): A propensity score analysis of treatment beyond second-line (PROSERpINA Study).

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. 3556-3556
Author(s):  
Maria Alessandra Calegari ◽  
Ina Valeria Zurlo ◽  
Michele Basso ◽  
Armando Orlandi ◽  
Maria Bensi ◽  
...  
Keyword(s):  
Propensity Score ◽  
Propensity Score Analysis ◽  
Chi Square ◽  
Treatment Line ◽  
Score Analysis ◽  
Secondary Endpoints ◽  
Retrospective Nature ◽  
Metastatic Sites ◽  
Ecog Ps

3556 Background: The optimal treatment for mCRC beyond 2nd line is still questioned. Recently, REG and TAS-102 showed to improve survival compared to BSC. While in real-world practice CTr/r is often considered in this setting, supporting evidences are limited. In absence of studies comparing all these strategies, we aimed to compare the prognostic performance of CTr/r, REG and TAS-102 in mCRC treated beyond 2nd line. Methods: mCRC pts progressing after at least 2 lines of CT, treated with CTr/r, REG or TAS-102 between Jan-10 and Jan-19 were considered eligible. The primary endpoint was OS; secondary endpoints were PFS and RR. Cox’s proportional hazard models for survivals were estimated. A propensity score (PS) adjustment for baseline characteristics was further accomplished for survival analysis. Results: The clinical data of 341 pts (CTr/r 133, REG 150, TAS-102 58) were retrospectively collected. At multivariate analysis type of treatment, ECOG PS, number of metastatic sites and treatment line independently correlated with OS ( p < .001, p .001, p < .001 and p .029, respectively). The mOS was 18.5 (95% CI, 14.3–22.7), 6 (95% CI, 5.6–9.5) and 7.6 months (95%CI, 5.6–9.5), for CTr/r, REG and TAS-102 group, respectively (log-rank p < .0001). mOS was significantly longer for pts receiving CTr/r than for those treated with REG/TAS-102 (15.8 vs 7.1 months; adjusted HR 1.96, 95% CI 1.44-2.66; p < .0001) at the PS analysis, adjusted for ECOG PS, number of metastatic sites and treatment line; 2-yrs OS was 34% and 11.6% for CTr/r and REG/TAS-102, respectively. PFS was significantly longer for pts receiving CTr/r than for those treated with REG/TAS-102 (5.5 vs 3.9 months; HR 1.45, 95% CI 1.11-1.91; p .006) at the PS analysis. Accordingly, RR was higher in pts receiving CTr/r compared to REG/TAS-102 (29.0 vs 1.5%; Chi-square p < .00001). Conclusions: Our analysis, although underpowered, generates the hypothesis of a superiority of CTr/r in comparison to REG or TAS-102, in both efficacy and activity. Given the retrospective nature of our analysis, and the potential role of selection bias in treatment assignment, a prospective validation is mandatory.

Sign in / Sign up

Export Citation Format

Share Document